JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13D, and any subsequent amendments thereto, to which this exhibit is attached is filed on behalf of each of them in the capacities set forth below.
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 24th day of February, 2014.
F2 BIOSCIENCE IV, L.P.
|
||
By: F2 Bioscience IV GP Ltd., General Partner
|
||
By: /s/ Xxxx Xxxxx
|
||
Name:
|
Xxxx Xxxxx, Director
|
|
|
||
F2 BIOSCIENCE IV GP LTD.
|
||
By: /s/ Xxxx Xxxxx
|
||
Name:
|
Xxxx Xxxxx, Director
|
|
|
||
F2 BIO VENTURES V, L.P.
|
||
By: F2 Bio Ventures GP Ltd., General Partner
|
||
By: /s/ Xxxxxx Xxxxxxxxxxxx
|
||
Name:
|
Xxxxxx Xxxxxxxxxxxx, Director
|
|
|
||
F2 BIO VENTURES GP LTD.
|
||
By: /s/ Xxxxxx Xxxxxxxxxxxx
|
||
Name:
|
Xxxxxx Xxxxxxxxxxxx, Director
|
|
|
||
GLOBEWAYS HOLDINGS LIMITED
|
||
By: /s/ Xxxxxxx Xxxxx /s/ Xxxxxxx XxXxxxxxx
|
||
Name:
|
Xxxxxxx Xxxxx, Clambake Limited & Xxxxxxx XxXxxxxxx, Cellar Limited, Directors of Corporate Directors
|